×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

TetraLogic Pharmaceuticals Corp. (TLOG) OTC MARKETS

- - (-)

Market Cap: $2432

As of 12/31/69 07:00 PM EST. Market open.

(TLOG)

TetraLogic Pharmaceuticals Corp. (TLOG)
OTC MARKETS

-
- (-)

Market Cap: $2432

As of 12/31/69 07:00 PM EST. Market open.

Add to Portfolio

tetralogic pharmaceuticals (nasdaq: tlog) is a clinical-stage biopharmaceutical company focused on discovering, acquiring and developing novel product candidates to treat cancer and infectious diseases. we currently have two clinical-stage product candidates in development: birinapant and suberohydroxamic acid (4-methoxycarbonyl) phenyl ester ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
PO Box 1305, Pennsylvania, Paoli, 19301-5305.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
10
Address
PO Box 1305, Pennsylvania, Paoli, 19301-5305.
PRICE CHART FOR TETRALOGIC PHARMACEUTICALS CORP
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
$0 - $0
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
100
Market Cap
$2432
Dividend Yield
-
P/E
-
Shares Outstanding
24,315,086
Open
-
Previous Close
-
Days Range
$0 - $0
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
100
Market Cap
$2432
Dividend Yield
-
P/E
-
Shares Outstanding
24,315,086
FINANCIAL STATEMENTS FOR TETRALOGIC PHARMACEUTICALS CORP
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TETRALOGIC PHARMACEUTICALS CORP
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Clarus Lifesciences II, L.P.10% OwnerFeb 09, 2016 Sale$0.16230,50736,8812,214,523Feb 10, 2016, 02:33 PM
Clarus Lifesciences II, L.P.10% OwnerFeb 08, 2016 Sale$0.19103,12319,5932,445,030Feb 10, 2016, 02:33 PM
Clarus Lifesciences II, L.P.10% OwnerFeb 03, 2016 Sale$0.1582,58312,3873,881,060Feb 05, 2016, 08:39 PM
Clarus Lifesciences II, L.P.10% OwnerFeb 05, 2016 Sale$0.20832,881166,5762,548,153Feb 05, 2016, 08:39 PM
Clarus Lifesciences II, L.P.10% OwnerFeb 04, 2016 Sale$0.14500,02670,0043,381,034Feb 05, 2016, 08:39 PM
Clarus Lifesciences II, L.P.10% OwnerFeb 02, 2016 Sale$0.17176,30629,9723,963,643Feb 02, 2016, 05:12 PM
Clarus Lifesciences II, L.P.10% OwnerFeb 01, 2016 Sale$0.20140,00028,0004,139,949Feb 02, 2016, 05:12 PM
Clarus Lifesciences II, L.P.10% OwnerJan 29, 2016 Sale$0.2652,82613,7354,279,949Feb 02, 2016, 05:12 PM
Clarus Lifesciences II, L.P.10% OwnerJan 26, 2016 Sale$0.3069,42520,8284,575,280Jan 28, 2016, 05:07 PM
Clarus Lifesciences II, L.P.10% OwnerJan 28, 2016 Sale$0.2632,5218,4554,332,775Jan 28, 2016, 05:07 PM
Clarus Lifesciences II, L.P.10% OwnerJan 27, 2016 Sale$0.27209,98456,6964,365,296Jan 28, 2016, 05:07 PM
Pecora Andrew LDirectorJul 10, 2015 Buy$2.6850,000133,944184,830Jul 14, 2015, 08:17 AM
Pecora Andrew LDirectorJul 09, 2015 Buy$2.4050,000120,090134,830Jul 13, 2015, 10:48 AM
Schmitt Paul JDirectorJul 02, 2015 Buy$2.3410,00023,35720,000Jul 06, 2015, 02:23 PM
Meyers Pete A.CFO & TreasurerMar 27, 2015 Buy$4.355,00021,750153,891Mar 31, 2015, 07:03 AM
BUCHI J KEVINPresident & CEOMar 26, 2015 Buy$4.235,00021,147330,714Mar 30, 2015, 07:43 AM
Begley Colin GlennChief Scientific Officer & SVPDec 10, 2014 Buy$6.166,00036,960198,234Feb 17, 2015, 03:33 PM
BUCHI J KEVINPresident & CEOJan 07, 2015 Buy$5.045,00025,181325,714Jan 09, 2015, 07:00 AM
Begley Colin GlennChief Scientific Officer & SVPDec 10, 2014 Buy$6.165,90036,344198,134Dec 12, 2014, 06:18 AM
BUCHI J KEVINPresident & CEODec 09, 2014 Buy$6.015,00030,060320,714Dec 11, 2014, 07:38 AM
Meyers Pete A.CFO & TreasurerDec 04, 2014 Buy$4.941,0345,108148,891Dec 08, 2014, 07:29 AM
BUCHI J KEVINPresident & CEODec 02, 2014 Buy$4.9910,00049,900315,714Dec 04, 2014, 07:30 AM
Begley Colin GlennChief Scientific Officer & SVPNov 26, 2014 Buy$4.871,1005,3521,100Dec 01, 2014, 11:47 AM
Begley Colin GlennChief Scientific Officer & SVPNov 26, 2014 Buy$4.862,0009,710192,234Dec 01, 2014, 11:47 AM
Russell LesleyChief Operating OfficerNov 26, 2014 Buy$4.9020,00097,97020,000Dec 01, 2014, 09:06 AM
Begley Colin GlennChief Scientific Officer & SVPNov 25, 2014 Buy$4.852,0009,707190,234Nov 28, 2014, 04:43 PM
BUCHI J KEVINPresident & CEONov 18, 2014 Buy$4.8210,00048,185305,714Nov 20, 2014, 08:31 AM
Pecora Andrew LDirectorNov 17, 2014 Buy$4.5320,00090,64084,830Nov 19, 2014, 12:36 PM
Meyers Peter A.CFO & TreasurerNov 12, 2014 Buy$3.985,00019,890147,857Nov 13, 2014, 02:20 PM
BUCHI J KEVINPresident and CEONov 11, 2014 Buy$3.9310,00039,325295,714Nov 13, 2014, 07:57 AM
Schmitt Paul JDirectorNov 10, 2014 Buy$4.1410,00041,35210,000Nov 12, 2014, 12:39 PM
Schmitt Paul JDirectorNov 10, 2014 Buy$4.0610,00040,63010,000Nov 12, 2014, 12:39 PM
Woody James N.DirectorDec 17, 2013 Option Exercise$7.00111,925783,475998,924Dec 19, 2013, 02:29 PM
Woody James N.DirectorDec 17, 2013 Buy$7.00261,4271,829,989261,427Dec 19, 2013, 02:29 PM
Woody James N.DirectorDec 17, 2013 Option Exercise$6.403,06419,6161,001,988Dec 19, 2013, 02:29 PM
Meyers Peter A.CFO & TreasurerDec 17, 2013 Buy$7.00142,857999,999142,857Dec 19, 2013, 12:54 PM
Schmitt Paul JDirectorDec 17, 2013 Option Exercise$7.00193,8631,357,0411,507,657Dec 19, 2013, 12:52 PM
Schmitt Paul JDirectorDec 17, 2013 Buy$7.00445,1793,116,253445,179Dec 19, 2013, 12:52 PM
Schmitt Paul JDirectorDec 17, 2013 Option Exercise$6.405,30533,9641,512,962Dec 19, 2013, 12:52 PM
BUCHI J KEVINPresident and CEODec 17, 2013 Buy$7.00285,7141,999,998285,714Dec 19, 2013, 12:52 PM
Pecora Andrew LDirectorDec 17, 2013 Option Exercise$7.005,88741,20964,669Dec 19, 2013, 12:51 PM
Pecora Andrew LDirectorDec 17, 2013 Buy$7.0026,551185,85742,727Dec 19, 2013, 12:51 PM
Pecora Andrew LDirectorDec 17, 2013 Option Exercise$6.401611,03164,830Dec 19, 2013, 12:51 PM
Clarus Lifesciences II, L.P.10% OwnerDec 17, 2013 Option Exercise$7.00853,4165,973,9124,621,423Dec 19, 2013, 12:49 PM
Clarus Lifesciences II, L.P.10% OwnerDec 17, 2013 Buy$7.001,425,0639,975,4411,425,063Dec 19, 2013, 12:49 PM
Clarus Lifesciences II, L.P.10% OwnerDec 17, 2013 Option Exercise$6.4023,282149,0564,644,705Dec 19, 2013, 12:49 PM
Gavin Brenda DDirectorDec 17, 2013 Option Exercise$7.0048,183337,281948,268Dec 19, 2013, 12:48 PM
Reed Douglas MDDirectorDec 17, 2013 Option Exercise$7.00278,3151,948,2051,202,152Dec 19, 2013, 12:47 PM
Reed Douglas MDDirectorDec 17, 2013 Buy$7.00142,857999,999142,857Dec 19, 2013, 12:47 PM
Reed Douglas MDDirectorDec 17, 2013 Option Exercise$6.407,59048,5931,209,742Dec 19, 2013, 12:47 PM
AMGEN INC10% OwnerDec 17, 2013 Buy$7.00272,1421,904,994541,399Dec 18, 2013, 06:09 PM
AMGEN INC10% OwnerDec 17, 2013 Option Exercise$6.401,1417,305269,257Dec 18, 2013, 06:09 PM
HEALTHCARE VENTURES VII LP10% OwnerDec 17, 2013 Option Exercise$6.98274,8701,919,7051,873,003Dec 17, 2013, 06:59 PM
HEALTHCARE VENTURES VII LP10% OwnerDec 17, 2013 Buy$7.00713,4634,994,2412,586,466Dec 17, 2013, 06:59 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Clarus Lifesciences II, L.P.10% Owner02/09/201636,881
Clarus Lifesciences II, L.P.10% Owner02/08/201619,593
Clarus Lifesciences II, L.P.10% Owner02/03/201612,387
Clarus Lifesciences II, L.P.10% Owner02/05/2016166,576
Clarus Lifesciences II, L.P.10% Owner02/04/201670,004
Clarus Lifesciences II, L.P.10% Owner02/02/201629,972
Clarus Lifesciences II, L.P.10% Owner02/01/201628,000
Clarus Lifesciences II, L.P.10% Owner01/29/201613,735
Clarus Lifesciences II, L.P.10% Owner01/26/201620,828
Clarus Lifesciences II, L.P.10% Owner01/28/20168,455
Clarus Lifesciences II, L.P.10% Owner01/27/201656,696
Pecora Andrew LDirector07/10/2015133,944
Pecora Andrew LDirector07/09/2015120,090
Schmitt Paul JDirector07/02/201523,357
Meyers Pete A.CFO & Treasurer03/27/201521,750
BUCHI J KEVINPresident & CEO03/26/201521,147
Begley Colin GlennChief Scientific Officer & SVP12/10/201436,960
BUCHI J KEVINPresident & CEO01/07/201525,181
Begley Colin GlennChief Scientific Officer & SVP12/10/201436,344
BUCHI J KEVINPresident & CEO12/09/201430,060
Meyers Pete A.CFO & Treasurer12/04/20145,108
BUCHI J KEVINPresident & CEO12/02/201449,900
Begley Colin GlennChief Scientific Officer & SVP11/26/20145,352
Begley Colin GlennChief Scientific Officer & SVP11/26/20149,710
Russell LesleyChief Operating Officer11/26/201497,970
Begley Colin GlennChief Scientific Officer & SVP11/25/20149,707
BUCHI J KEVINPresident & CEO11/18/201448,185
Pecora Andrew LDirector11/17/201490,640
Meyers Peter A.CFO & Treasurer11/12/201419,890
BUCHI J KEVINPresident and CEO11/11/201439,325
Schmitt Paul JDirector11/10/201441,352
Schmitt Paul JDirector11/10/201440,630
Woody James N.Director12/17/2013783,475
Woody James N.Director12/17/20131,829,989
Woody James N.Director12/17/201319,616
Meyers Peter A.CFO & Treasurer12/17/2013999,999
Schmitt Paul JDirector12/17/20131,357,041
Schmitt Paul JDirector12/17/20133,116,253
Schmitt Paul JDirector12/17/201333,964
BUCHI J KEVINPresident and CEO12/17/20131,999,998
Pecora Andrew LDirector12/17/201341,209
Pecora Andrew LDirector12/17/2013185,857
Pecora Andrew LDirector12/17/20131,031
Clarus Lifesciences II, L.P.10% Owner12/17/20135,973,912
Clarus Lifesciences II, L.P.10% Owner12/17/20139,975,441
Clarus Lifesciences II, L.P.10% Owner12/17/2013149,056
Gavin Brenda DDirector12/17/2013337,281
Reed Douglas MDDirector12/17/20131,948,205
Reed Douglas MDDirector12/17/2013999,999
Reed Douglas MDDirector12/17/201348,593
AMGEN INC10% Owner12/17/20131,904,994
AMGEN INC10% Owner12/17/20137,305
HEALTHCARE VENTURES VII LP10% Owner12/17/20131,919,705
HEALTHCARE VENTURES VII LP10% Owner12/17/20134,994,241
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR TETRALOGIC PHARMACEUTICALS CORP
LOADING...